Evaxion Biotech A/S revenue breakdown overview

Evaxion Biotech A/S revenue for the last year amounted to 3.34 M USD, the most of which — 3.34 M USD — came from its highest performing source at the moment, Artificial Intelligence-Immunology Powered Vaccines, the year earlier bringing 73.00 k USD. The greatest contribution to the revenue figure was made by Denmark — last year it brought Evaxion Biotech A/S 3.34 M USD, and the year before that — 73.00 k USD.